PT Siloam International Hospitals Tbk (FRA:2LS) Ending Cash Position: €43.1 Mil (As of Mar. 2026)


FRA:2LS PT Siloam International Hospitals Tbk FRA:2LS
94 GF Score
Price €0.10
GF Value €0.12
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Siloam International Hospitals Tbk Ending Cash Position?

PT Siloam International Hospitals Tbk FRA:2LS 94 Ending Cash Position is €43.1 Mil as of Mar. 2026. GuruFocus rates FRA:2LS with a GF Score™ of 94/100 and a GF Value™ of €0.12 (Modestly Undervalued). The stock has 2 warning signs investors should review.

PT Siloam International Hospitals Tbk's Ending Cash Position for the quarter that ended in Mar. 2026 was €43.1 Mil.

PT Siloam International Hospitals Tbk's quarterly Ending Cash Position increased from Sep. 2025 (€44.0 Mil) to Dec. 2025 (€57.9 Mil) but then declined from Dec. 2025 (€57.9 Mil) to Mar. 2026 (€43.1 Mil).

PT Siloam International Hospitals Tbk's annual Ending Cash Position declined from Dec. 2023 (€70.1 Mil) to Dec. 2024 (€61.9 Mil) and declined from Dec. 2024 (€61.9 Mil) to Dec. 2025 (€57.9 Mil).

PT Siloam International Hospitals Tbk Ending Cash Position Related Terms

PT Siloam International Hospitals Tbk Ending Cash Position Historical Data

* Premium members only.

The historical data trend for PT Siloam International Hospitals Tbk's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Siloam International Hospitals Tbk Ending Cash Position Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.25 63.21 70.11 61.92 57.86

PT Siloam International Hospitals Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.80 33.92 44.02 57.86 43.06
FRA:2LS
94GF Score
PT Siloam International Hospitals Tbk FRA:2LS
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Siloam International Hospitals Tbk Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PT Siloam International Hospitals Tbk's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=53.143+4.712
=57.9

PT Siloam International Hospitals Tbk's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=57.831+-14.767
=43.1

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €43.1 Mil mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Ending Cash Position of €43.1 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Siloam International Hospitals Tbk and its competitors.
Is PT Siloam International Hospitals Tbk's Ending Cash Position too high?
PT Siloam International Hospitals Tbk's current Ending Cash Position is €43.1 Mil. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Ending Cash Position compare to HCA and THC?
PT Siloam International Hospitals Tbk's Ending Cash Position of €43.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Siloam International Hospitals Tbk and its competitors. PT Siloam International Hospitals Tbk's current Ending Cash Position is €43.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.12, compared to a current price of €0.10 — trading 19.2% below its estimated fair value. The current Ending Cash Position is €43.1 Mil. PT Siloam International Hospitals Tbk's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Ending Cash Position is €43.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued. The current stock price of €0.10 is trading 19.2% below its estimated GF Value™ of €0.12. GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.

Key valuation signals for FRA:2LS:

  • Ending Cash Position: €43.1 Mil
  • GF Value™: €0.12 vs. price of €0.10 (19.2% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Siloam International Hospitals Tbk Business Description

Other Exchanges SILO:Indonesia
Address No. 15, Jalan Boulevard Sudirman, Floor 32, Gedung Fakultas Kedokteran Universitas Pelita Harapan, Lippo Village, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
94GF Score

Get the complete analysis for FRA:2LS

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.12
GF Value